Plus therapeutics presents positive cnside csf assay platform results at the 2025 sno/asco cns metastases conference

Cnside® can quantify leptomeningeal metastases (lm) over time and monitor changes in the expression of multiple targetable mutations

PSTV Ratings Summary

PSTV Quant Ranking